Should Health Systems Build Or Buy Their Healthcare AI In 2027?

A few years ago I started crying in a meeting and couldn't stop.

Not a dignified single tear down the cheek. A full structural collapse, in front of colleagues, over nothing anyone in the room could actually name. My brain had been running hot for two straight years and I genuinely hadn't noticed, because every dashboard I looked at was green. Revenue fine. Team fine. Me, allegedly, fine.

I got the accounting wrong, and I've thought about it a lot since. The expensive part was never the breakdown itself. It was the two years of quiet maintenance I'd been performing on myself without ever once counting it as work.

That's the exact line item missing from most build-versus-buy spreadsheets too.

What does building healthcare AI in-house actually cost?

Roughly $4M to $15M a year for a real internal practice, and 9 to 18 months before a single clinician touches anything.

Taction's 2026 build-versus-buy decision framework puts a hospital system's in-house AI engineering practice at 8 to 15 engineers plus a clinical informatics team, against a five-year operational ownership commitment. The comparison they draw is blunt: a wrong build decision burns 18 months and over $1M producing something that could have been licensed for $80K a year.

Partnering sits in between. 12 to 24 weeks to a first production user, somewhere between $45K and $450K depending on scope.

Those are the numbers. They are not the decision.

Why does the build-versus-buy math keep going wrong?

Because organizations price construction and forget maintenance.

James Aita made this point sharply in Healthcare Business Today. Coding systems update annually. Quality measures evolve. Interoperability expectations expand. Every one of those changes ripples through content, mappings, validation rules, and reporting logic, and somebody internal has to track it, implement it, test the downstream effects, and preserve historical accuracy.

At some point maintenance stops being a background task and quietly becomes a primary operational function.

AI doesn't reduce that burden either. It stacks models, evals, monitoring, and governance on top of it.

Build once is a capital expense. Keep it current forever is a permanent staffing decision nobody actually signed up for in the original business case. And when the architect who understood it leaves, which they will, the whole thing becomes an archaeology project.

What should a health system never outsource?

The workflow and the data. Just those two, but absolutely those two.

Buy the model layer if you want to. Foundation models are not your differentiation and building one is an enormous distraction from the work. But the moment your escalation logic, your clinical thresholds, and your patient data all live inside a vendor's black box, you've outsourced the exact thing you remain legally and morally accountable for.

That isn't hypothetical. If your system can't inspect what happened on one specific patient call, it cannot be accountable for that call. And "the vendor assures us it's fine" has never once satisfied a quality committee, in any hospital, anywhere.

This is why we design every clinical use case so the escalation path is configured by the clinic and readable by the clinic, not buried in a model prompt somebody else owns.

Is there a third option besides build and buy?

Yes, and it's the one most frameworks skip entirely: buy the software, own the deployment.

Open-source and self-hosted collapses a tradeoff the six-dimension frameworks treat as fixed. You get buy-grade time to value, weeks instead of eighteen months. You get build-grade data control, because PHI never leaves your infrastructure. You get auditable clinical logic, because you can actually read it and so can your compliance team.

We built HANA this way on purpose, after watching health systems get trapped in relationships where they couldn't move their own data, couldn't audit a decision made about their own patient, and couldn't answer a straightforward compliance question without filing a support ticket and waiting nine days. The integration documentation is public for the same reason. You should be able to evaluate whether it fits your stack before anyone signs anything.

It isn't free, and I won't pretend otherwise. Self-hosting means you own uptime, and somebody on your side has to genuinely care about that at two in the morning.

How should a health system actually decide?

Answer four questions before you compare a single vendor.

Is this use case a high-volume standard category or is it specialty-specific? Vendors have mature products for primary-care ambient documentation and basic vitals alerting. They are consistently weak on behavioral health crisis monitoring, OB-specific intake, and procedure-specific complication detection. Specialty depth pushes you toward partner, build, or self-host.

Does your data posture actually permit vendor-controlled retention? If you're on-prem-only, or you've had a breach that hardened policy, buy is a non-starter no matter how good the demo felt.

What are the per-encounter economics at your projected scale rather than your pilot scale? Per-clinician subscriptions that look cheap across 40 users behave very differently across 4,000.

And who owns this on day four hundred? If you can't name that person, you aren't making a build-versus-buy decision at all. You're scheduling a future orphan.

We publish what deployments cost and what they actually delivered because those should be comparable numbers, not something you have to book a call to extract.

Key Takeaways

The build-versus-buy question is usually framed as a cost comparison, and framed that way it's almost always answered wrong. Construction is the cheap part. Maintenance is where budgets quietly go to die, and AI compounds that burden rather than relieving it. The dimensions that should actually drive the decision are specialty fit, data control posture, per-encounter economics at real scale, and named operational ownership on day four hundred. Most systems can buy the model layer safely and should. Almost none of them should hand over the workflow logic or the patient data, because those are the parts a regulator, a family, or a quality committee will eventually ask them to explain. Self-hosted open-source sits in a middle ground the standard frameworks barely acknowledge, and for a lot of systems it's the honest answer. If you want to pressure-test your own use case against these four questions, book a call and bring the real numbers.

FAQ

Is it cheaper to build or buy healthcare AI?

Buying is cheaper for the first three years in almost every high-volume standard category. Building only wins economically at genuine scale, and only when the organization already has MLOps maturity and clinical informatics depth in place. A realistic in-house practice runs $4M to $15M annually before you count opportunity cost.

What are the hidden costs of building AI in-house?

Maintenance is the one that breaks budgets. Terminology updates, quality measure changes, interoperability requirements, model drift, eval harnesses, and audit tooling all need continuous work, and that work concentrates inside one organization instead of being spread across many. Key-person risk sits underneath all of it.

Can a health system keep its data on-premises and still use AI?

Yes. Self-hosted, open-source deployment keeps PHI entirely inside your own infrastructure with no third-party model dependency, which satisfies on-prem-only policies that make conventional vendor contracts impossible. You trade some operational convenience for full data control and auditable clinical logic.